Eltrombopag 50mg tablets
NHS hospitals in England used £20,096,306 of indicative cost of Eltrombopag 50mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 1.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Eltrombopag 50mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Eltrombopag 50mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £746,240 |
| University College London Foundation Tr | £590,053 |
| Sheffield Teaching Hospitals Nhs Trust | £589,820 |
| Maidstone And Tunbridge Wells Nhs Trust | £566,500 |
| University Hpls North Midlands Nhs Trust | £550,055 |
| United Lincolnshire Hospitals Nhs Trust | £545,820 |
| Leeds Teaching Hpls Nhs Trust | £525,250 |
| South Tyneside And Sunderland Nhs Ft | £475,365 |
| Derby Teaching Hospitals Nhs Found Trust | £465,740 |
| Cambridge Univ Hosp Nhs Foundation Trust | £434,170 |
The primary-care picture
Eltrombopag is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Eltrombopag medicine page.